Not applicableUnknownNCT05253638What this trial is testingEvaluation Of Serum MIF Level in SLE PatientsWho this might be right forSystemic Lupus Erythematosus Assiut University 60
Early research (Phase 1)Study completedNCT01953835What this trial is testingA Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184Who this might be right forSystemic Lupus Erythematosus GlaxoSmithKline 37
Not applicableUnknownNCT04534647What this trial is testingSerological and Urinary Biomarkers in Latin American Patients With Systemic Lupus Erythematosus: GLADEL 2.0 CohortWho this might be right forLupus Nephritis Liga Panamericana de Asociaciones de Reumatologia (PANLAR) 100
Not applicableLooking for participantsNCT07515638What this trial is testingImmun4Cure Cohort of Autoimmune DiseasesWho this might be right forRheumatoid ArthritisSystemic Lupus ErythematosusSystemic Sclerosis+1 more University Hospital, Montpellier 500
Testing effectiveness (Phase 2)Looking for participantsNCT03673748What this trial is testingTreatment of Lupus Nephritis With Allogeneic Mesenchymal Stem CellsWho this might be right forLupus NephritisLupus Erythematosus Red de Terapia Celular 20
Testing effectiveness (Phase 2)Study completedNCT00774852What this trial is testingAbatacept and Cyclophosphamide Combination Therapy for Lupus NephritisWho this might be right forLupus NephritisLupus Erythematosus, Systemic National Institute of Allergy and Infectious Diseases (NIAID) 137
Not applicableUnknownNCT05007340What this trial is testingILD-SARDs Registry and BiorepositoryWho this might be right forInterstitial Lung DiseaseSystemic Autoimmune DiseaseRheumatic Diseases+6 more McGill University Health Centre/Research Institute of the McGill University Health Centre 252
Not applicableNot Yet RecruitingNCT07083349What this trial is testingNK510 Cell Therapy for Refractory Systemic Lupus ErythematosusWho this might be right forRefractory Systemic Lupus Erythematosus Base Therapeutics (Shanghai) Co., Ltd. 9
Early research (Phase 1)Study completedNCT00818948What this trial is testingSafety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without GlomerulonephritisWho this might be right forNephritisSystemic Lupus Erythematosus Amgen 56
Not applicableWithdrawnNCT03937271What this trial is testingObjective Measurement Methods for Autoimmune Disease and Dry Eye SyndromeWho this might be right forSjögren's SyndromeSystemic Lupus ErythematosusRheumatoid Arthritis+3 more Taipei Veterans General Hospital, Taiwan
Not applicableStudy completedNCT00004663What this trial is testingEpidemiologic Study of Reproductive Outcome in Women With Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus National Center for Research Resources (NCRR) 480
Early research (Phase 1)Looking for participantsNCT07219563What this trial is testingAlnuctamab for Refractory SLE (LATTE Study)Who this might be right forSystemic Lupus Erythematosus Icahn School of Medicine at Mount Sinai 21
Not applicableLooking for participantsNCT07121777What this trial is testingAnti CD19/BCMA CAR Gene Therapy for Autoimmune DiseasesWho this might be right forAutoimmune Diseases Anhui Provincial Hospital 18
Not applicableStudy completedNCT04397107What this trial is testingThe Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic DiseasesWho this might be right forSystemic Lupus Erythematosus The First Hospital of Jilin University 46
Early research (Phase 1)Study completedNCT06955598What this trial is testingA Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of SHR-2173 in Patients With Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Guangdong Hengrui Pharmaceutical Co., Ltd 30
Not applicableStudy completedNCT02950714What this trial is testingDissemination of the Lupus Interactive NavigatorWho this might be right forSystemic Lupus Erythematosus CHU de Quebec-Universite Laval 541
Testing effectiveness (Phase 2)Study completedNCT01449071What this trial is testingStudy Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus Erythematosus UCB Pharma 20
Very early researchLooking for participantsNCT07617740What this trial is testingIASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)Who this might be right forREFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS Peking University People's Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT07570862What this trial is testingA Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisWho this might be right forLupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more Fate Therapeutics 53
Testing effectiveness (Phase 2)Looking for participantsNCT06032923What this trial is testingDouble-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus (Sle) National Heart, Lung, and Blood Institute (NHLBI) 78